ask our doctors

Acne Vulgaris

Get the facts on Acne Vulgaris treatment, diagnosis, staging, causes, types, symptoms. Information and current news about clinical trials and trial-related data, Acne Vulgaris prevention, screening, research, statistics and other Acne Vulgaris related topics. We answer all your qestions about Acne Vulgaris.

Question: What is the tetracycline dosage for Acne vulgaris ? what is the dosage for acne vulgaris with 250mg tetracycline caps ?

Answer: it is usually 2 twice a day an hour before food , and is usually taken for at least 8 weeks


Acne Vulgaris News

Glaxo's Acne Drug Gets US Nod

Zacks.com
Fabior Foam, 0.1% is approved as a topical treatment for acne vulgaris in patients 12 years and above. The approval was based on data from two pivotal phase III studies conducted with Fabior Foam. The 12-week, randomized and double-blind trials were ...
 

New acne treatment: GSK's topical Fabior Foam gets FDA approval

MedCity News
Tazarotene, which will be marketed under the name Fabior Foam, is a topical foam developed to treat acne vulgaris. Fabior now has US Food and Drug Administration approval to treat the moderate-to-severe acne in patients who are 12 or older.
 

Stiefel receives US FDA approval of Fabior(TM) Foam, 0.1%

MarketWatch (press release)
It is the only retinoid in a topical foam formulation for the treatment of acne vulgaris in patients 12 years of age and older. "Stiefel is dedicated to meeting the needs of patients and dermatologists and we believe Fabior Foam will be an important ...
 

My daughter has bad acne!

Jamaica Gleaner
Acne affects over 85 per cent of people at some point, especially adolescents. Acne vulgaris involves inflammation of the hair follicle and its attached oil-producing gland (sebaceous gland). Its main causes include hormones stimulating sebaceous ...
 

Stiefel receives US FDA approval of Fabior? Foam, 0.1%

Sacramento Bee
It is the only retinoid in a topical foam formulation for the treatment of acne vulgaris in patients 12 years of age and older. "Stiefel is dedicated to meeting the needs of patients and dermatologists and we believe Fabior Foam will be an important ...
 

Acne Through the Ages

SkinInc.com
Acne ultimately results in an overproduction of sebum, a buildup of dead skin cells and an accumulation of bacteria. Some people experience mild noninflamed acne called acne simplex, while others have inflamed acne or acne vulgaris, which is severe and ...
 

MURDOCK Study seeks people with acne

CorneliusNews.net
The study needs people ages 12 to 18 who have a current or previous diagnosis of acne vulgaris and who have received oral medicines in their treatment, including Accutane, Amnesteem, Claravis, and Sotret. Children must have parental consent.
 

SOHM India Pvt. Ltd, an Indian Subsidiary of SOHM, Inc., Enters Into an ...

MarketWatch (press release)
SOHM ensures that its innovative focus is reinforced by adding a Foam preparation in its Salic-2 Face Wash product mix in the management of acne vulgaris. Mr. Shailesh Shah, president & CEO of SOHM, Inc., has denoted, "These are only baby steps from ...
 

Galderma Italy Deploys Comprehensive Cegedim Relationship Management Cloud ...

MarketWatch (press release)
... across the world that treat a range of dermatological conditions including: acne vulgaris, rosacea, fungal nail infections, psoriasis and steroid-responsive dermatoses, pigmentary disorders, medical solutions for skin senescence and skin cancers.
 

XOMA's CEO Discusses Q1 2012 Results - Earnings Call Transcript

Seeking Alpha
Let's turn to our moderate to severe inflammatory acne vulgaris Phase 2 proof-of-concept study. As we have indicated in prior communications, we are seeking to enroll 171 patients over 18 years of age, who are diagnosed with moderate to severe acne ...